On December 29, 2021, the California Department of Health Care Services (DHCS) announced that a California State’s Medicaid (Medi-Cal) pilot program had been approved by the Centers for Medicare and Medicaid Services (CMS). The pilot program titled California Advancing, and Innovating Medi-Cal (CalAIM) aims to make the Medi-Cal program more equitable, coordinated, and person-centered through scaling innovation statewide and aligning care delivery systems. Notably, the program expands access to evidence-based contingency management for substance use disorders (SUDs) which includes expanding access to prescription digital therapeutics (PDTs). PDTs are evidence-based medical interventions that use software that can be accessed on a tablet or smartphone to prevent, manage, or treat SUDs. Aimed Alliance leads ACTION for PDTs, a multi-disciplinary collaboration working to expand the adoption, coverage, and access to PDTs for individuals with chronic disease. We applaud Governor Newsom’s initiation of this pilot program and CMS approval making this program permanent. Read the news release here.
Last Updated on January 7, 2022 by Aimed Alliance
